Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study-Reference-Cited by-同舟云学术

Effectiveness and Safety of Fecal Microbiota Transplantation for Clostridioides Difficile Infection: Results From a 5344-Patient Cohort Study

Published:2022-07 Issue:1 Volume:163 Page:319-322
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Osman Majdi^ORCID,Budree Shrish,Kelly Colleen R.,Panchal Pratik,Allegretti Jessica R.,Kassam Zain,Olesen Scott W.,Ramakrishna Bharat,Dubois Nancy,O’Brien Kelsey,Fischer Monika,Stollman Neil,Hays R. Ann,Kelly Ciarán P.,Amaratunga Kanchana,Qazi Taha,Crothers Jessica W.,Abend Audrey,Bougas Michael,Burns Laura,Decaille-Hodge Imani,Dickens Michael,Edelstein Carolyn,Gabdrakhmanova Dinara,Kerwin Clara,Landry Richard,Ling Kelly,Martin Daniel,Medina Geraldine,Mendolia Gina,Muñoz Rodrigo,Rao Sanjay,Seng Monica,Smith Mark,Stehler Laura,Yoder Karl,Zellmer Caroline

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference10 articles.

1. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections

2. Faecal microbiota transplantation for Clostridium difficile ‐associated diarrhoea: a systematic review of randomised controlled trials

3. Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

4. Donor Screening for Fecal Microbiota Transplantation

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing CD8⁺ T cell dynamics in hepatitis B virus‐associated liver diseases: Insights, therapies and future directions;Clinical and Translational Medicine;2024-06-27

2. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines;Journal of Hospital Infection;2024-06

3. A decade of insight: bibliometric analysis of gut microbiota’s role in osteoporosis (2014–2024);Frontiers in Medicine;2024-05-22

4. Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection;Frontiers in Microbiomes;2024-05-16

5. The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines;Gut;2024-04-12